MML Investors Services
ASND icon

MML Investors Services’s Ascendis Pharma A/S ASND Stock Holding History

MML Investors Services’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+757
New +$177K ﹤0.01% 3110
2025
Q1 		– Sell
-1,644
Closed -$226K – 2688
2024
Q4 		$226K Buy
+1,644
New +$216K ﹤0.01% 2440

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

MML Investors Services's ASND Position: Q2 2026 in Review

MML Investors Services opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 757 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #3110 among its holdings. This is a return to the name: MML Investors Services previously reported a position in ASND as recently as Q4 2024.

MML Investors Services first reported a position in ASND in Q4 2024 and has held it in 2 quarters since. The position peaked at $226K in Q4 2024. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • MML Investors Services held 757 shares of Ascendis Pharma A/S worth $202K as of Q2 2026.
  • Ascendis Pharma A/S was a new MML Investors Services position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #3110 holding.
  • MML Investors Services first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 2 quarters since.
  • MML Investors Services's Ascendis Pharma A/S position peaked at $226K in Q4 2024.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.